SCOPUS 정보 검색 플랫폼

Current Opinion in Biotechnology

Volumn 12, Issue 3, 2001, Pages 304-307

The evolution of public review and oversight mechanisms in human gene transfer research: Joint roles of the FDA and NIH

(3) Friedmann, Theodore a Noguchi, Philip b Mickelson, Claudia c

a UNIVERSITY OF CALIFORNIA (United States)

b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (United States)

c MASSACHUSETTS INSTITUTE OF TECHNOLOGY (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT DNA;

BIOMEDICINE; FOOD AND DRUG ADMINISTRATION; GENE THERAPY; GENE TRANSFER; GOVERNMENT; HEALTH CARE ORGANIZATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION; RESEARCH; REVIEW; UNITED STATES;

EID: 0035368689 PISSN: 09581669 EISSN: None Source Type: Journal
DOI: 10.1016/S0958-1669(00)00216-0 Document Type: Review

Times cited : (13)

References (6)

1
- 85031514833
- September 8
- (1995) Ad hoc review committee executive summary of findings and recommendations report, and recommendations of the panel to assess the NIH investment in research on gene therapy

2
- 85031515910
- Federal register, October 31, (62 FR 59031)
- (1997) Recombinant DNA research: actions under the guidelines

3
- 85031509358
- Federal Register, October 10, (65 FR 60327)
- (2000) Office of Biotechnology Activities; recombinant DNA research: action under the guidelines

5
- 85031509358
- Federal Register December 12, (65 FR 77655)
- (2000) Office of Biotechnology Activities; recombinant DNA research: proposed actions under the NIH guidelines

6
- 85031513591
- Federal Register, January 18, (66 FR 4688)
- (2001) Food and Drug Administration; proposed rule

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.